Oxycodone is a semisynthetic opioid analgesic derived from thebaine in Germany in 1917. It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period. The first oxycodone containing product, Percodan, was approved by the FDA on April 12, 1950.
Oxycodone is indicated for the treatment of moderate to severe pain. There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.
Kuopio University Hospital, Kuopio, Northern Savo, Finland
Kuopio University Hospital, Kuopio, Northern Savo, Finland
Kuopio University Hospital, Kuopio, Northern Savo, Finland
Jean Brown Research, Salt Lake City, Utah, United States
Investigational center, City name, United Kingdom
Roswell Park Cancer Institute, Buffalo, New York, United States
University of Minnesota, Minneapolis, Minnesota, United States
Dep of Urology Bern University Hospital, Bern, Switzerland
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.